USPTO serial 75586231
PROJECT IMPACT HYPERLIPIDEMIA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 28, 1999
- Examiner
- CROSS, TRACY L
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PROJECT IMPACT HYPERLIPIDEMIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
American Pharmaceutical Association (APhA) Foundation
Washington, DC
Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
American Pharmaceutical Association (APhA) Foundation
Washington, DC
Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
American Pharmaceutical Association (APhA) Foundation
Washington, DC
Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph L. Morales
Joseph L. Morales Whiteford, Taylor & Preston LLPSeven Saint Paul StreetBaltimore, MD 21202-1636UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | MEDICAL RESEARCH AND TESTING, AND PROVIDING HEALTH INFORMATION IN THE FIELD OF PHARMACEUTICAL SCIENCE | SECTION 8 - CANCELLED | Mar 8, 1998 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
- Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
- Other trademarks owned by American Pharmaceutical Association (APhA) Foundation
- Other trademarks in Class 042
- Similar marks named PROJECT IMPACT HYPERLIPIDEMIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 31, 2010 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Mar 31, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 31, 2006 | CFIT | CASE FILE IN TICRS | — |
| Jan 31, 2006 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jan 31, 2006 | PLGL | ASSIGNED TO PARALEGAL | — |
| Dec 20, 2005 | 815F | REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED | — |
| Dec 20, 2005 | PAPER RECEIVED | — | |
| Dec 28, 1999 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 5, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 1999 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 21, 1999 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 1999 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| May 11, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| May 11, 1999 | DOCK | ASSIGNED TO EXAMINER | — |